American Spectrum Realty Stock (OTC: AQQSQ)

Latest news for American Spectrum Realty (OTC:AQQSQ) Stock

American Spectrum Realty Inc is a real estate investment company. The company owns and manages commercial, industrial, retail, self-storage, multi-family and student housing income properties.

AMER SPECTRUM RLTY INC by American Spectrum Realty, Inc.

American Spectrum Realty Inc

JP Morgan analyst Sean Meakim maintains Baker Hughes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>) with a Overweight and raises the price target from $42 to $43.

News

Price Target

Analyst Ratings

JP Morgan Maintains Overweight on Baker Hughes, Raises Price Target to $43

RBC Capital analyst Keith Mackey reiterates NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) with a Sector Perform and maintains $24 price target.

Reiteration

RBC Capital Reiterates Sector Perform on NOV, Maintains $24 Price Target

Keefe, Bruyette &amp; Woods analyst Wood Lay maintains Origin Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OBK#NYSE">OBK</a>) with a Outperform and raises the price target from $38 to $39.

Keefe, Bruyette & Woods Maintains Outperform on Origin Bancorp, Raises Price Target to $39

WIIM

BMRC

Bank of Marin shares are trading lower after the company reported worse-than-expected Q2 earnings.

Keefe, Bruyette &amp; Woods analyst Kelly Motta maintains National Bank Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBHC#NYSE">NBHC</a>) with a Market Perform and raises the price target from $39 to $45.

NBHC

Keefe, Bruyette & Woods Maintains Market Perform on National Bank Holdings, Raises Price Target to $45

Oil prices continue to experience a sluggish trend, with West Texas Intermediate (WTI) light crude trading flat at just under $78 a <a href="https://www.benzinga.com/topic/oil">barrel on Monday morning</a>. This stagnation persists even as rising tensions in the Middle East have failed to significantly impact oil prices.
<h3 class="wp-block-heading">Middle East heats up again</h3>
On Sunday, Israel&#8217;s security cabinet authorized Prime Minister Benjamin Netanyahu&#8216;s government to decide on the manner and timing of a response to a deadly rocket strike in the Israeli-occupied Golan Heights.
The attack, which killed 12 teenagers and children, has been attributed to the Lebanese armed group Hezbollah by both Israel and the United States.
Israel reported that an Iranian-made missile launched from southern Lebanon caused the deaths, holding Iranian-backed Hezbollah responsible.
However, Hezbollah has firmly denied any involvement in the strike, the deadliest in Israel or Israeli-controlled territory since Hamas&#8217; October 7 assault, which initiated the Gaza conflict. In retaliation, Israeli jets targeted sites in southern Lebanon on Sunday.
Turkish President Tayyip Erdogan suggested over the weekend that Turkey might intervene in Israel, similar to its actions in Libya and Nagorno-Karabakh. 
Vice President Kamala Harris, the Democratic presidential candidate, reiterated her &#8220;ironclad&#8221; support for Israel's security. The U.S. has been in talks with Israeli and Lebanese officials since the attack, seeking a diplomatic solution. Secretary of State Antony Blinken stressed that Washington aims to avoid further escalation of the conflict.
Reuters reported Monday morning that Israel aims to weaken Hezbollah without triggering a full-scale war in the Middle East. However, the situation remains highly volatile.
<h3 class="wp-block-heading">China&#8217;s Crude Oil Imports Struggle</h3>
Chinese crude oil imports continue to decline, indicating a struggling recovery in the world&#8217;s second-largest economy. 
Crude oil imports in China fell by 11% in June 2024 compared to the same month in 2023, amid weak fuel demand and lower run rates at independent refineries. This represents the sharpest year-over-year decline in crude imports since June 2022.
In June, crude imports totaled 46.45 million metric tons, or approximately 11.3 million barrels per day (bpd). The average utilization rate of independent refineries in Shandong fell to 52% in June, the lowest since the pandemic began in 2020, according to local information provider JLC cited by S&amp;P Global. The utilization rate was previously lower, at 43.8% in February 2020.
In the first half of 2024, crude arrivals also dropped, by 2.3% compared to the first half of last year, according to data from China's General Administration of Customs. 
<h3 class="wp-block-heading">Oil Technical Analysis: Breakout Looms</h3>
&#8220;Oil prices have been trading in a narrowing range, or a triangle pattern, for over a year now,&#8221; wrote Bank of America Technical Strategist Paul Ciana, in a note shared Monday.
A technical triangle pattern is a chart formation indicating consolidation and potential breakout, formed by converging trendlines representing the asset&#8217;s highs and lows.
Bank of America estimates a breakout in crude prices between August and October 2024.
The current wave count links this pattern to the urban legend of the Bermuda Triangle, where things mysteriously disappear. Ciana suggests that a loss of macro risk premium, global demand, and/or supply cut hopes could lead to a decline in oil prices to $63 or $60 a barrel by the end of 2024. 
A weekly close in Brent below $78 &#8220;would look like a bearish triangle breakdown,&#8221; Ciana stated. Conversely, bulls must push oil prices higher. A weekly close above $89 per barrel could trigger a bullish surge to $105 per barrel.
The United States Oil Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>), which closely tracks the performance of the WTI light crude, has risen 13% year to date, yet it is down by over 4% in July. 
Chart: Oil Prices In A Triangle Pattern, With Momentum Weakening 
<figure class="wp-block-image size-large"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent072924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="379" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/29103157/image-55-1024x379.png" alt="" class="wp-image-462618" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/29103157/image-55-1024x379.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/29103157/image-55-300x111.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/29103157/image-55-768x284.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/29103157/image-55-1536x569.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/29103157/image-55.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Image: <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent072924&amp;t=be2bearmibe3na1">Benzinga Pro</a> 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/40013144/if-economic-performance-were-an-olympic-sport-us-economy-would-win-gold-says-market">If Economic Performance Were An Olympic Sport, &#8216;US Economy Would Win Gold,&#8217; Says Market Veteran</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Analyst Color

Asia

Macro Economic Events

Specialty ETFs

Commodities

Politics

Econ #s

Economics

ETFs

Oil Prices Remain Under Pressure Despite Rising Middle East Tensions: 'A Bearish Triangle Breakdown' Looms

NUWE

Nuwellis shares are trading higher after the company announced the first pediatric patient was treated in a commercial setting with SeaStar Medical's QUELIMMUN therapy.

Keefe, Bruyette &amp; Woods analyst Damon Delmonte maintains Midland States Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSBI#NASDAQ">MSBI</a>) with a Market Perform and lowers the price target from $26 to $24.

MSBI

Keefe, Bruyette & Woods Maintains Market Perform on Midland States Bancorp, Lowers Price Target to $24

U.S. stocks were mixed, with the Dow Jones index falling more than 100 points on Monday.
Shares of ON Semiconductor Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) rose sharply during Monday's session after the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/07/40010835/on-semiconductor-q2-earnings-revenue-and-eps-beat-ceo-highlights-automotive-gains-strong-q3-outlook">second quarter financial results</a>.
ON Semiconductor reported a fiscal second-quarter 2024 revenue decline of 17.2% year-on-year to $1.74 billion, beating the analyst consensus estimate of $1.73 billion. The adjusted EPS of 96 cents beat the analyst consensus estimate of 92 cents per share, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
ON Semiconductor said it expects third-quarter adjusted revenue of $1.70 billion – $1.80 billion, versus the consensus of $1.73 billion. The company sees adjusted EPS of 91 cents to $1.03 versus the consensus of 92 cents.
ON Semiconductor shares jumped 13.7% to $79.76 on Monday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>NIP Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIPG#NASDAQ">NIPG</a>) shares jumped 34.4% to $12.25.</li>
<li>Meta Data Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIU#NYSE">AIU</a>) shares gained 23.5% to $2.9860.</li>
<li>Oil States International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OIS#NYSE">OIS</a>) shares jumped 18.8% to $5.63 after the company reported better-than-expected second-quarter financial results.</li>
<li>CommScope Holding Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COMM#NASDAQ">COMM</a>) gained 17.2% to $2.25 after reporting preliminary second quarter results.</li>
<li>Serve Robotics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) rose 16.1% to $15.35.</li>
<li>Koninklijke Philips N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) climbed 13.1% to $29.14 after the company reported better-than-expected second quarter earnings.</li>
<li>The Shyft Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHYF#NASDAQ">SHYF</a>) gained 11.2% to $15.33. DA Davidson analyst Michael Shlisky upgraded Shyft Group from Neutral to Buy and raised the price target from $12 to $18.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) gained 8.5% to $18.48. ZIM Integrated Shipping Services will release its second quarter financial results on Monday, Aug. 19.</li>
<li>Oscar Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>) jumped 8.1% to $17.09.</li>
<li>Aehr Test Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) gained 6.6% to $19.06.</li>
<li>Castle Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSTL#NASDAQ">CSTL</a>) gained 6.4% to $22.40.</li>
<li>DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) rose 6% to $67.97.</li>
<li>MaxLinear, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MXL#NYSE">MXL</a>) jumped 5.7% to $13.51.</li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rose 5.6% to $232.15. Morgan Stanley analyst Adam Jonas reiterated Tesla with an Overweight and maintained a $310 price target.</li>
<li>Foot Locker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) gained 4.5% to $27.65. On July 18, Morgan Stanley downgraded the stock from Equal-Weight to Underweight and lowered its price target from $24 to $18.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/40011827/more-than-4m-bet-on-appian-check-out-these-3-stocks-insiders-are-buying">More Than $4M Bet On Appian? Check Out These 3 Stocks Insiders Are Buying</a></li>
</ul>

Intraday Update

Markets

Movers

Trading Ideas

AEHR

COMM

CSTL

DXCM

NIPG

OSCR

SERV

SHYF

TSLA

ON Semiconductor Posts Upbeat Earnings, Joins Oil States International, CommScope Holding And Other Big Stocks Moving Higher On Monday

RBC Capital analyst Nik Modi maintains Newell Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) with a Sector Perform and raises the price target from $7.5 to $9.5.

RBC Capital Maintains Sector Perform on Newell Brands, Raises Price Target to $9.5

JP Morgan analyst Sebastiano Petti maintains Charter Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) with a Neutral and raises the price target from $300 to $385.

CHTR

JP Morgan Maintains Neutral on Charter Communications, Raises Price Target to $385

Keefe, Bruyette &amp; Woods analyst Damon Delmonte reiterates MidWestOne Financial Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOFG#NASDAQ">MOFG</a>) with a Market Perform and raises the price target from $25 to $28.

MOFG

Keefe, Bruyette & Woods Reiterates Market Perform on MidWestOne Financial Gr, Raises Price Target to $28

Keefe, Bruyette &amp; Woods analyst Damon Delmonte maintains Lakeland Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKFN#NASDAQ">LKFN</a>) with a Market Perform and raises the price target from $64 to $65.

LKFN

Keefe, Bruyette & Woods Maintains Market Perform on Lakeland Financial, Raises Price Target to $65

RBC Capital analyst Arun Viswanathan maintains Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) with a Outperform and lowers the price target from $61 to $52.

RBC Capital Maintains Outperform on Olin, Lowers Price Target to $52

General

Speaker Johnson Says President Biden's Supreme Court Reform Proposal Is 'Dead On Arrival' In The House

Keefe, Bruyette &amp; Woods analyst Catherine Mealor maintains Independent Bank Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBTX#NASDAQ">IBTX</a>) with a Outperform and raises the price target from $57 to $66.

IBTX

Keefe, Bruyette & Woods Maintains Outperform on Independent Bank Gr, Raises Price Target to $66

JP Morgan analyst Samik Chatterjee maintains Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) with a Overweight and raises the price target from $47 to $55.

JP Morgan Maintains Overweight on Corning, Raises Price Target to $55

Ventyx Biosciences Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTYX#NASDAQ">VTYX</a>) stock is trading lower on Monday.
The company released results from the Phase 2 trial of allosteric TYK2 inhibitor VTX958 in participants with moderately to <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/g40008627/ventyx-biosciences-announces-results-from-the-phase-2-trial-of-vtx958-in-participants-with-moderat" rel="noreferrer noopener">severely active Crohn&#8217;s disease</a>, a type of&nbsp;inflammatory bowel disease that irritates and causes swelling in digestive tract.
The Phase 2 trial enrolled 109 participants randomized to one of two VTX958 doses (225 mg and 300 mg twice daily) or placebo for a 12-week induction treatment period, followed by a long-term extension period.
The primary endpoint was the change in the mean Crohn&#8217;s disease activity index (CDAI) score (a patient-reported outcome that determines the current severity of Crohn&#8217;s disease) from baseline to Week 12.
A key secondary endpoint in this trial was the endoscopic response, defined as a 50% reduction in the simple endoscopic score for Crohn&#8217;s disease (SES-CD).
The trial did not meet its primary endpoint of change in mean CDAI score due to a higher-than-anticipated placebo response.
A dose-dependent treatment effect was observed on the key secondary endpoint of endoscopic response at 225 mg and 300 mg doses (nominal p-value &lt;0.05 and &lt;0.01, respectively).
Endoscopic response, evaluated by centrally read endoscopy, is considered an objective outcome and a high-priority treatment goal.
Both doses of VTX958 also showed a greater magnitude of decrease compared to the placebo in two key biomarkers of inflammation, C-reactive protein, and fecal calprotectin.
VTX958 was well tolerated in the Phase 2 trial. The overall safety profile was consistent with previously conducted trials of VTX958.
Based on these results, the company intends to conduct further data analyses. Currently, Ventyx does not anticipate conducting additional clinical trials of VTX958 with internal resources.
The company held cash, cash equivalents, and marketable securities of $279.7 million as of June-end, which is expected to fund planned operations into at least the second half of 2026.
Price Action: VTYX stock is down 24.6% at $2.225 at last check Monday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/40014064/life-science-firm-revvity-lifts-annual-profit-forecast-on-strong-q2-performance" target="_blank" rel="noreferrer noopener">Life Science Firm Revvity Lifts Annual Profit Forecast On Strong Q2 Performance</a>.</li>
</ul>

Biotech

Equities

Health Care

VTYX

Ventyx Biosciences' Inflammatory Bowel Disease Candidate Flunks In Mid-Stage Study, Company Looks For Partner To Pursue It Further

$BTC

Benzinga Market Summary: Bitcoin Rises On Trump Backing, McDonald's Reverses Course After Earnings Miss, Morgan Stanley Reiterates Bull Rating On Tesla

Arweave's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">AR</a>) price has increased 4.71% over the past 24 hours to $31.96. Over the past week, AR has experienced an uptick of over 1.0%, moving from $31.86 to its current price. As it stands right now, the coin's all-time high is $89.24. 
The chart below compares the price movement and volatility for Arweave over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1722265346_0.png" alt="price_chart" />
The trading volume for the coin has tumbled 44.0% over the past week along with the circulating supply of the coin, which has fallen 0.18%. This brings the circulating supply to 65.45 million, which makes up an estimated 99.17% of its max supply of 66.00 million. According to our data, the current market cap ranking for AR is #50 at $2.10 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1722265346_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

American Spectrum Realty

News

Latest news for American Spectrum Realty (OTC:AQQSQ) Stock